Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 11Recruiting 5Unknown 2Not yet recruiting 2Withdrawn 1Terminated 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 19Rectal Neoplasms 10Colonic Neoplasms 10Pancreatic Neoplasms 3Neoplasm Metastasis 3Carcinoma, Hepatocellular 3Unspecified Adult Solid Tumor, Protocol Specific 2Triple Negative Breast Neoplasms 2Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sezary Syndrome 1Sarcoma 1Retinoblastoma 1Pancreatic Adenocarcinoma Metastatic 1Ovarian Neoplasms 1Neuroblastoma 1Neoplasms 1Mycosis Fungoides 1Motor Activity 1Melanoma 1Malignant Tumor of Pancreas Metastatic to Liver 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Non-Hodgkin 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia 1Immunoblastic Lymphadenopathy 1Gastrointestinal Neoplasms 1

Interventions

Gemcitabine 3Cisplatin 3Irinotecan 2Fluorouracil 2Capecitabine 2tremelimumab 1pamiparib 1durvalumab 1brigimadlin 1atezolizumab 1Temozolomide 1Surgical Procedures, Operative 1Paclitaxel 1Oxaliplatin 1Nivolumab 1Leucovorin 1IMC-001 1Blood Specimen Collection 1ARX788 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Biliary Tract Neoplasms × Leucovorin × Clear all
NCT03110510 2022-06-15

FOLFIRI as Salvage Treatment in Metastatic Biliary Tract Cancer (BTC) Patients Who Were Failed After Gemcitabine Containing Chemotherapy: A Phase II Single Arm Prospective Study

Samsung Medical Center

Phase 2 Withdrawn
Gastrointestinal

Biliary Tract Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡